The resulting lawsuits (brought by payers and the FTC) highlight how non-pharmacologic patents can be exploited
While its been designed to help with appetite control, it wont work as well if you continue eating high-calorie low-nutrient foods
FDA Approvals Reflect Evidence Base Based on these cardiovascular outcome trials, the FDA has approved three semaglutide formulations for cardiovascular risk reduction
Additionally, 32% of participants using Mounjaro lost a quarter of their body weight, while only 16% of Wegovy users achieved the same milestone
If you have diabetes and notice a sweet, fruity odour (particularly on your breath), this could potentially indicate diabetic ketoacidosis, which requires urgent medical assessment
This study was intended to provide descriptive insights into the real-world use, weight outcomes, and dosing among patients treated with semaglutide 2.4 mg and tirzepatide